Search results
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 42 minutes agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Ohio company gets greenlight from FDA to test Cuban drug for diabetic foot ulcers
The Cleveland Plain Dealer· 13 hours agoCLEVELAND, Ohio— Cleveland-based biotechnology company Discovery Therapeutics Caribe will soon be...
Q1 2024 Nautilus Biotechnology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoParticipants Sujal Patel; Founder & CEO; Nautilus Biotechnology Inc Parag Mallick; Co-Founder, Chief Scientist; Nautilus Subsidiary Inc Anna Mowry; Chief Financial Officer ...
Aurinia: Q1 Earnings Snapshot
Houston Chronicle· 1 hour agoEDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $10.7 million in its first quarter. On a per-share basis, the Edmonton, Alberta-based company said ...
Short Interest in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Rises By 5.6%
ETF DAILY NEWS· 9 hours agoIovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares ...
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 hours agoOn May 1, 2024, United Therapeutics Corp (NASDAQ:UTHR) released its latest 10-Q filing, revealing a...
Galapagos NV (NASDAQ:GLPG) Short Interest Update
ETF DAILY NEWS· 9 hours agoGalapagos NV (NASDAQ:GLPG – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 1,500,000 shares, an increase ...
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
GuruFocus.com via Yahoo Finance· 1 day agoExplore key financial outcomes and strategic insights from Nautilus Biotechnology's first quarter of 2024, emphasizing growth in expenses and future expectations.
Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
Simply Wall St. via Yahoo Finance· 3 days agoThis article is for those who would like to learn about Return On Equity (ROE). By way of...
Ascendis Pharma A/S (NASDAQ:ASND) Sees Large Growth in Short Interest
ETF DAILY NEWS· 6 hours agoAscendis Pharma A/S (NASDAQ:ASND – Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 3,600,000 shares, a growth of 7.5% ...
